Journal profile · ONCOLOGY
Journal of Liquid Biopsy
ISSN 2950-1954
Journal of Liquid Biopsy: impact factor 5 (journal website); fully open access; APC about USD 2,080; median 39 days to acceptance (102 articles, last 24 months); 145 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, Journal of Liquid Biopsy's largest topics are Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Cancer Cells and Metastasis, together about 49.2% of its articles. Its main subfields are Oncology and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Liquid Biopsy aims to cover the research insight into the molecular pathways analyzed by using liquid biopsy-based biomarkers (cfDNA, ctDNA, miRNA, CTC, extracellular vesicles, protein, etc.) and their relative clinical implication. An integrated approach that includes molecular findings, technical aspects, and clinical data is encouraged to provide a comprehensive view of liquid biopsy. The editors welcome papers that: Clarify molecular mechanisms behind analytes relapse in torrent blood;Provide a clinical interpretation of molecular insights regarding the implementation of liquid biopsy-related biomarkers;Identify technical issues for liquid biopsy-related biomarkers identification, detection, and analysis;Promote novel technical strategies capable of successfully evaluating the molecular landscape of liquid biopsy-related biomarkers.The Journal of Liquid Biopsy is the official open-access scientific journal of the International Society of Liquid Biopsy (ISLB). Members of the ISLB receive a 25% discount on their Open Access fee.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Umberto MalapellePublisher website
Editorial board by country: none in mainland China; most named United States 9, Italy 6, Spain 4, Japan 2, Canada 1 (25 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology30.3%
- Lung Cancer Treatments and MutationsMedicine12.1%
- Cancer Cells and MetastasisMedicine6.8%
- Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology4.6%
- Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology4.2%
- Genetic factors in colorectal cancerMedicine3.7%
- Cancer Immunotherapy and BiomarkersMedicine3.3%
- Lung Cancer Research StudiesMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 5Publisher website ·
- CiteScore (publisher)
- 3.7Publisher website ·
- h-index
- 17OpenAlex ·
- i10-index
- 38OpenAlex ·
- 2-year mean citedness
- 3.13OpenAlex ·
- Self-citation rate
- 16%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 49LetPub ·
Articles by year OpenAlex count · 457 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 23 |
| 2025 | 145 | 145 | 463 |
| 2024 | 132 | 132 | 538 |
| 2023 | 130 | 130 | 309 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
39 daysMedian, submission to acceptance · P25–P75 29 days – 56 days
- Acceptance to online
- median 3 days (102 articles)
- Submission to online
- median 44 days
- Sample
- 102 articles with submission and acceptance dates (120 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 3 daysPublisher website ·
- Submission to acceptance
- 37 daysPublisher website ·
- Acceptance to publication
- 3 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,080 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,080 / EUR 1,900 / GBP 1,670 / JPY 257,980 | — | — | |
| Publisher website | USD 2,080 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Article types accepted9, with length limits
- editorialsEditorials. Editorials are solicited by the editor and are generally related to a paper published in the same issue.Length not stated
- from the lab ? visual protocolsFrom the Lab ? Visual Protocols. These are short, structured articles, which primarily use illustrative schematic summaries or videos to convey step-by-step des…Length not stated
- letters to the editorLetters to the editor are exclusively for correspondence relating to recently published articles. The letter should not exceed 500 words and 5 references, inclu…main text ≤ 500 words · references ≤ 5
- original articleOriginal studies should be related to the molecular pathways analysed by using liquid biopsy-based biomarkers (cfDNA, ctDNA, miRNA, CTC, extracellular vesicles,…main text ≤ 4,000 words · abstract ≤ 300 words
- original articlesOriginal articles. Original studies should be related to the molecular pathways analysed by using liquid biopsy-based biomarkers (cfDNA, ctDNA, miRNA, CTC, extr…Length not stated
- review articlettention from the scientific community. Review articles should not exceed 5,000 words in length (excluding abstract, references, acknowledgments,main text ≤ 5,000 words · abstract ≤ 300 words · references ≤ 100
- review articlesReview articles. Review articles should summarize the state-of-the-art or focus on the recent advances in a particular topic/technique.Length not stated
- short communicationThese are brief papers that make a specific well-documented point. Such communications are limited to 1,500 words, 3 tables and/or figures, 25 references, and t…main text ≤ 1,500 words · abstract ≤ 250 words · references ≤ 25
- short communicationsShort communications. These are brief papers that make a specific well-documented point.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal follows a double anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2950-1954
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Liquid Biopsy
What is the impact factor of Journal of Liquid Biopsy?
The journal's website gives an impact factor of 5; this is the journal's own figure, as LetPub lists none for it; h-index 17.
How long does peer review take at Journal of Liquid Biopsy?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 39 days (interquartile range 29–56 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Liquid Biopsy based?
Of the 25 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), Italy (6) and Spain (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Liquid Biopsy?
According to LetPub and DOAJ records, Journal of Liquid Biopsy is indexed in ESCI and DOAJ.
Is Journal of Liquid Biopsy open access, and what is the APC?
Journal of Liquid Biopsy is a fully open-access journal. APC about USD 2,080.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .